Diabetes Mellitus and Thyroid Cancers: Risky Correlation, Underlying Mechanisms and Clinical Prevention
Rongqian Wu,Junping Zhang,Guilin Zou,Shanshan Li,Jinying Wang,Xiaoxinlei Li,Jixiong Xu
DOI: https://doi.org/10.2147/dmso.s450321
2024-02-16
Diabetes Metabolic Syndrome and Obesity Targets and Therapy
Abstract:Rongqian Wu, 1– 3 Junping Zhang, 1– 3 Guilin Zou, 1– 3 Shanshan Li, 1 Jinying Wang, 1 Xiaoxinlei Li, 1 Jixiong Xu 1– 3 1 Department of Endocrinology and Metabolism, The 1st Affiliated Hospital, Jiangxi Medical College, Nanchang University, Nanchang, People's Republic of China; 2 Jiangxi Clinical Research Center for Endocrine and Metabolic Disease, Nanchang, People's Republic of China; 3 Jiangxi Branch of National Clinical Research Center for Metabolic Disease, Nanchang, People's Republic of China Correspondence: Jixiong Xu, Email The incidences of thyroid cancer and diabetes are rapidly increasing worldwide. The relationship between thyroid cancer and diabetes is a popular topic in medicine. Increasing evidence has shown that diabetes increases the risk of thyroid cancer to a certain extent. This mechanism may be related to genetic factors, abnormal thyroid-stimulating hormone secretion, oxidative stress injury, hyperinsulinemia, elevated insulin-like growth factor-1 levels, abnormal secretion of adipocytokines, and increased secretion of inflammatory factors and chemokines. This article reviews the latest research progress on the relationship between thyroid cancer and diabetes, including the association between diabetes and the risk of developing thyroid cancer, its underlying mechanisms, and potential anti-thyroid cancer effects of hypoglycemic drugs. It providing novel strategies for the prevention, treatment, and improving the prognosis of thyroid cancer. Keywords: diabetes, thyroid cancer, underlying mechanisms, hypoglycemic drugs Diabetes is a chronic metabolic disease characterized by elevated blood glucose levels and is the most common endocrine disease. The rapid development of the global economy has brought about lifestyle changes and accelerated aging population, resulting in an increasing prevalence of diabetes each year. About 537 million adults worldwide have diabetes, and type 2 diabetes accounts for nearly 90%. 1,2 Thyroid cancer is the most common malignant tumor of the endocrine system, and it originates from the thyroid follicular epithelial cells. In recent years, the incidence of thyroid cancer has increased significantly, making it the fastest-growing tumor globally. It is expected to become the fourth most common type of malignant tumor worldwide. 3,4 Thyroid carcinoma encompasses various subtypes, including papillary thyroid carcinoma (PTC), follicular thyroid carcinoma, medullary thyroid carcinoma, and anaplastic thyroid carcinoma according to the histological origin. PTC is the most common subtype of thyroid carcinoma. 5 The incidence of concurrent diabetes and malignant tumors is increasing worldwide. The correlation between diabetes and malignant tumors has always been a research hotspot in medicine. A century ago, some scholars have proposed that there may be a link between diabetes and malignant tumors. 6 Clinical studies have confirmed that diabetes is a high-risk factor for various malignant tumors. Notably, the occurrence and development of breast, gastric, colorectal, and pancreatic cancers are closely associated with diabetes. 7–10 Through an examination of the clinical data from patients with diabetes and thyroid cancer, we found that the risk of thyroid cancer was significantly increased in patients with diabetes. With the increasing incidence of thyroid cancer, it is necessary to analyze the correlation between thyroid cancer and diabetes to provide valuable insights for the prevention and improving prognosis of thyroid cancer. This article presents a comprehensive review of the latest research findings on the association between thyroid cancer and diabetes, including the risk factors associated with the diseases, their shared pathogenesis, and the potential impact of hypoglycemic medications on thyroid cancer. More and more studies have shown that diabetes can affect the risk of thyroid cancer (Table 1). A 10-year prospective study reported a 25% increased risk of thyroid cancer in patients with diabetes; the study also revealed that the risk of thyroid cancer in females with diabetes was significantly higher than that in males with diabetes. 11 A retrospective cohort study demonstrated that although thyroid cancer is rare among men, those with diabetes had a 40% higher thyroid cancer risk than women, emphasizing that there is a significantly higher risk in patients with diabetes. 12 Yeo et al observed that in areas with a high incidence of thyroid cancer, the risk of thyroid cancer in female patients with diabetes increased by 30%, while the risk in male patients did not increase. 13 Zhan et al observed that patients with a history of diabetes and high fasting blood glucose levels -Abstract Truncated-
endocrinology & metabolism